GO:0160255 tRNA queuosine(34) biosynthetic process from salvaged queuine

GO:0160255, tRNA queuosine(34) biosynthetic process from salvaged queuine, is a biological process that describes how cells generate the modified nucleoside queuosine at position 34 of tRNA using queuine that has been salvaged rather than synthesized de novo. Queuosine is a hypermodified base found in the anticodon loop of tRNAs that carry the GUN anticodon, and its presence influences codon recognition and translational fidelity. The salvage route is particularly important because it allows cells to reuse queuine obtained from the environment or from the turnover of existing tRNA, making the pathway economically favorable under conditions where de novo synthesis is absent or inefficient. Researchers study this process because it connects tRNA modification, translation, and cellular metabolism. In Bartonella henselae, the salvage pathway follows a unique evolutionary trajectory that differs from canonical bacterial routes, suggesting that the enzymes and transport steps involved can vary across species. In fission yeast, the enzyme Qng1 mediates hydrolysis of queuosine to queuine, providing a salvage mechanism that supports tRNA modification. In humans, the absence of tRNA-guanine transglycosylase in a colon adenocarcinoma cell line indicates that defects in queuosine incorporation can occur in cancer and may affect translation. Understanding GO:0160255 therefore requires integrating knowledge of queuine transport, enzymatic modification, and tRNA function. The pathway also intersects with broader questions about how cells respond to nutrient availability and how tRNA modifications regulate gene expression. Because queuine can be salvaged from the environment, the process is sensitive to the presence of queuine or its precursors, and transport proteins such as YhhQ in Escherichia coli are involved in the uptake of related queuosine precursors. This makes GO:0160255 a useful entry point for studying metabolic salvage, tRNA biology, and the evolutionary diversity of modification pathways.

GO:0160255 is defined as the chemical reactions and pathways resulting in the formation of tRNA queuosine(34) by salvaging available queuine. In other words, it covers the steps by which a cell takes up or recycles free queuine and incorporates it into tRNA at position 34, producing the queuosine modification without relying on de novo synthesis of the queuine base. This process includes the transport or availability of queuine, its enzymatic transfer to tRNA, and the resulting modified tRNA species.

GO:0160255 is important because queuosine modification at tRNA position 34 affects codon-anticodon interactions and translational efficiency, and the salvage route allows cells to maintain this modification using available queuine rather than costly de novo synthesis. Defects in queuosine incorporation, such as the absence of tRNA-guanine transglycosylase in a human colon adenocarcinoma cell line, have been linked to cancer cell biology, suggesting that this pathway can influence disease-relevant processes. In addition, the transport and salvage steps are species-specific, as shown by the unique evolutionary path in Bartonella henselae and by the involvement of YhhQ in precursor transport in E. coli, making this term a focal point for comparative and functional studies.

The following genes and proteins are directly implicated in queuine salvage, transport, or tRNA modification based on the verified literature.

The salvage pathway is regulated by the availability of queuine and the expression or activity of transport and modification enzymes. In E. coli, YhhQ is involved in the transport of preQ0, suggesting that precursor uptake can influence flux through the pathway. In fission yeast, Qng1-mediated hydrolysis of queuosine to queuine provides a regulatory node for recycling and maintaining queuine pools. In Bartonella henselae, the unique evolutionary path of queuosine salvage implies species-specific regulatory features. In human cells, the absence of tRNA-guanine transglycosylase in a colon adenocarcinoma cell line indicates that loss of enzyme activity can shut down the pathway, which may be subject to genetic or epigenetic regulation.

The absence of tRNA-guanine transglycosylase in a human colon adenocarcinoma cell line demonstrates that queuosine incorporation can be lost in cancer cells. This loss may affect translation and contribute to the malignant phenotype, making the salvage pathway a potential area for cancer research. Because queuosine modification influences codon recognition, its deficiency could alter the translation of specific mRNAs.

Bartonella henselae uses a unique evolutionary path for queuosine salvage, which may be important for its survival and pathogenesis. Understanding this pathway could reveal vulnerabilities in the bacterium that can be targeted therapeutically. The involvement of transport proteins such as YhhQ in E. coli further highlights the potential for targeting uptake or salvage steps in bacteria.

Queuine salvage is linked to the availability of queuine and the recycling of queuosine, which can affect translational fidelity under stress. In fission yeast, Qng1-mediated salvage supports queuosine formation, and its disruption could impact growth or stress responses. These connections suggest that the pathway may be relevant to diseases involving translational dysfunction.

Knockout of genes such as tgt, Qng1, or yhhQ can reveal their requirement for queuosine salvage and tRNA modification. Point mutations can be used to dissect catalytic residues or transport functions. These approaches are foundational for assigning gene function in GO:0160255.

Direct detection of queuosine at tRNA position 34 can be achieved using RNA sequencing or mass spectrometry-based methods. These techniques allow researchers to quantify the modification and assess the impact of genetic perturbations. Comparing wild-type and mutant strains can confirm the role of specific genes in the salvage pathway.

In vitro assays using recombinant enzymes can measure transglycosylation or hydrolysis activities, as demonstrated for Qng1 and tRNA-guanine transglycosylase. Such assays provide direct evidence for the biochemical steps in GO:0160255. They can also be used to test substrate specificity and inhibitor effects.

Transport of queuine or precursors can be studied using radiolabeled substrates or fluorescent analogs in bacterial systems such as E. coli. These assays help define the role of transporters like YhhQ in the salvage pathway. They are also useful for comparing transport efficiency across species.

Researchers studying tRNA queuosine(34) biosynthetic process from salvaged queuine-related genes often need to determine whether a candidate gene is causally involved in queuine salvage, tRNA modification, or downstream translation. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.

GO:0160255, tRNA queuosine(34) biosynthetic process from salvaged queuine, is a specialized salvage pathway that ensures queuosine modification of tRNA using available queuine. Its components, including tRNA-guanine transglycosylase, Qng1, and transport proteins like YhhQ, have been characterized in diverse organisms, revealing both conserved and species-specific features. The pathway is relevant to cancer biology and bacterial metabolism, making it a valuable target for further research. By combining CRISPR-based genetic models with RNA modification and biochemical assays, researchers can dissect the molecular details of this pathway and its impact on translation and disease. EDITGENE offers a full suite of services to support such studies, from knockout and point mutation models to library screening and bioinformatics.